Consumer digital health app for... ⭐ Today's idea

FlareCast - Gout Flare Predictor

Know your gout flare before it hits

A mobile gout management app that learns each patient's personal triggers from low-effort logs, hydration, medication adherence, sleep and uric acid readings. It then gives a daily, transparent flare-risk signal so users can act before an attack. It also produces doctor-ready reports.

First revenue
90-150 days
Capital
$15K-$40K
Difficulty
High
Year one
$15K-$30K
Ceiling
$3M-6M ARR

Researched 7 Nov 2026

At a glance Verdict: watch
Pain Acute, recurring, vocal
Cost to build Moderate; ML and data
Pricing room Free tiers cap price
Competition Nine gout apps already
Distribution Reddit-led, low search
01 · Summary

Clean diet, same flares: gout still feels random

Concept page, generated from the research
Who it's for
adults with gout and recurring flares, especially those on urate-lowering therapy, who log symptoms and food manually
What it does
a mobile app that turns low-effort daily check-ins, hydration, sleep, medication adherence and uric acid results into a transparent, personalized daily flare-risk signal with plain-language reasons and doctor-ready reports
What changes
Guessing at random flares and keeping a diary becomes a 30-second daily check-in and a clear warning before the next attack.
Biggest risk
Gout Compass already markets a daily 0-100 flare-risk score with wearable inputs, and GoutIQ offers AI-suggested flare predictions, so prediction is not unique.
02 · Why now

App-supported gout care just beat usual care 85% to 49%

Google Trends · search interest
gout 3% stable
gout flare 200% rising
gout symptoms -33% stable
gout treatment -33% stable
uric acid 10% stable
Timing signals

A smartphone-run gout programme hit the urate target in 85% of patients vs 49% on usual care (reported Nov 4, 2026), as FDA and Australia's TGA loosened rules for self-management software in early 2026.

adoption Nov 2026

A 12-month single-centre trial of 280 men found 85% on an app-supported treat-to-target model reached the serum-urate goal, versus 49% (48.6%) on usual care (open-label, one hospital; published in Arthritis & Rheumatology and reported Nov 4, 2026).

Health Newspapers
regulation 2026-01

On January 6, 2026, the FDA published revised final guidance on Clinical Decision Support Software and its General Wellness Policy for Low Risk Devices, updating the rules that govern digital health products.

Ropes & Gray
regulation 2026-03

Australia's TGA published guidance on 16 March 2026 explaining when consumer software for self-managing an existing disease or health condition may be excluded from its regulatory requirements. It published a companion guidance on the general health or wellness software exclusion the same day.

Therapeutic Goods Administration (TGA)
technology 2026-03

The ReMonit Gout feasibility study (published March 2026) tested a self-management app in a digital treat-to-target gout-care approach, from researchers at Diakonhjemmet Hospital in Oslo.

Scandinavian Journal of Rheumatology (Taylor & Francis)
adoption 2026-05

A randomized controlled trial of a smart gout management system (published May 2026) improved self-management ability, serum uric acid control and renal markers in suburban community patients.

EMJ Reviews
technology 2026-06

A June 2026 Arthritis Care & Research study evaluated the reliability of an electronic, self-reported gout flare assessment against staff-conducted telephone questionnaires. It was run within the TRUST trial, which uses flares as its primary outcome, and the study notes that assessing gout flares is difficult.

Arthritis Care & Research
Est. TAM $1.8B · SAM $420M market ~16% growth
03 · Evidence

Gout patients, in their own words

6 quotes
9/10
pain severity, raised repeatedly
In a 12-month single-centre trial of 280 men, 85% of those on a smartphone app-supported treat-to-target gout model reached the serum-urate goal, versus 48.6% (reported as 49%) on usual care (open-label, one hospital; published Nov 2026).
Health Newspapers (citing Arthritis & Rheumatology)
Gout affects more than 1 in 40 people in the UK and is increasing globally; flares are intermittent, severely painful hot swollen joints (EPCC/NHS Lothian, June 2025).
EPCC (University of Edinburgh)
The global mHealth apps market was USD 18.42 billion in 2025 and is forecast to reach USD 143.6 billion by 2035, a 23.1% CAGR.
Emergen Research
★ 9/10

“i need to know if this is normal. i know what i consume for the past few days wouldn't cause flare up. I'm keeping up with my allopurinol and i take extreme care of what i eat daily. i need advice.how to stop this fro...”

★ 8/10

“Now im at 9.7 after cleaning up my diet, back to back flares for the last 6 months. No meat, no alcohol, no added sugars.”

★ 7/10

“Sometimes we put in a lot of effort for 4–6 months—following a proper diet, staying hydrated, exercising, and making lifestyle changes—and the uric acid level still seems to rise suddenly, sometimes followed by anothe...”

★ 6/10

“I’d like to get a better understanding of which foods trigger my attacks. Are they are any apps that are particularly good for this for gout? I’ve never tracked my food consumption like this so something with a low ba...”

04 · Market

Everyone logs flares; almost no one predicts them

8 competitors mapped
Transparent, multi-si...
GoutSnap
Urica Free / Pro
Flarebreak Free / Premium
GoutIQ Free
G Gout Compass
F FlareCast $7.99/mo
Multi-signal inputs (non-di... →
Logs what happened Predicts what's next →
Product From What it does The gap
Flarebreak Free forever (unlimited f... Gout tracking app for logging flares, uric acid readings and appoin... Triggers are logged manually by the user ('what you think...
Gout Buddy Gout-focused self-management app named by the builder as a known co... —
Gout-Cha! Free €0 forever; Premium ... Gout tracking app covering meals, flares, medication, water and uri... —
Gout Guru Gout app with daily check-ins, flare logs and uric acid trends that... Its developer described it on Reddit as 'pretty bare-bone...
GoutIQ App free; 28-Day Low-Puri... Free gout tracking web app for food, drinks, flares and uric acid, ... Web app rather than a native mobile app
GoutSnap Inc Gout app that scans meals to show purine load, tracks uric acid and... —
GoutTrack App for logging gout flares, uric acid and food that detects the fo... —
Urica Free (3 meal analyses/day... Gout tracker that scores meals from 1 to 10 using USDA purine data,... Meal portions are estimated from photo or description (pe...
05 · Verdict

Watch it. Prediction alone is not a moat.

watch medium confidence

The pain is real and the prediction gap is open, but at least nine gout apps already compete and Gout Compass already ships a daily flare-risk score, so only build if you can prove a measurably better prediction wedge.

✓Why it works

  • +The top Reddit pain, flares despite strict diet and allopurinol adherence, is high-frequency and emotionally intense, and food-centric trackers like Urica and GoutSnap don't explain it.
  • +Why-now evidence is strong: an app-supported gout programme hit the urate target in 85% vs 49% of patients (Nov 2026), and the FDA (Jan 2026) and TGA (Mar 2026) loosened guidance for self-management and wellness software.
  • +Most competitors are retrospective trackers; only Gout Compass and GoutIQ's opt-in AI attempt forward-looking risk, leaving room for a transparent, non-dietary prediction layer.
  • +Willingness to pay has precedent: Gout-Cha! Premium at €79.99/yr and GoutIQ meal plans at $27-34, with doctor reports gated behind paid tiers at Urica and Flarebreak.

!What could kill it

  • −Gout Compass already markets a daily 0-100 flare-risk score with wearable inputs, and GoutIQ already offers AI flare predictions, so 'prediction' alone is not a moat.
  • −Free tiers are the norm (Flarebreak, GoutIQ, Gout-Cha!, Urica), which caps pricing and keeps free-to-paid conversion at 3-5%.
  • −Flare prediction accuracy needs data and ideally clinical validation; a bad prediction could erode trust or invite regulatory scrutiny.
  • −Search demand is tiny ('gout flare' volume 2), so growth depends on Reddit communities and app-store discovery against GoutSnap's 260+ reviews.

Risks & mitigations

Gout Compass already markets a daily 0-100 flare-risk score with wearable inputs, and GoutIQ offers AI-suggested flare predictions, so prediction is not unique.

High

Mitigation: Differentiate on transparent reasons, non-dietary triggers and backtested accuracy shown inside the app. Publish accuracy metrics and pursue an academic or clinic partnership to validate.

Prediction accuracy may be weak with sparse personal data; GoutIQ itself says predictions are 'possibilities, not guarantees', and a wrong signal erodes trust fast.

High

Mitigation: Show confidence bands, start with a rules-based prior, label scores as estimates, and measure precision and recall on beta users before charging for the prediction tier.

Regulatory exposure: the FDA's revised Clinical Decision Support and General Wellness guidance (Jan 2026) and the TGA's self-management software guidance (Mar 2026) set limits. Claims of predicting or avoiding flares could push the app towards device territory.

Medium

Mitigation: Keep claims to self-management and wellness, avoid diagnosing or recommending treatment changes, and get a regulatory review before launch in each market, starting with the US and Australia.

Free tiers from Flarebreak, GoutIQ, Gout-Cha! and Urica anchor pricing near zero and could keep free-to-paid conversion below the 3-5% assumption.

Medium

Mitigation: Keep logging and basic history free, charge only for prediction, trigger insights and reports, and test price points with beta users before launch.

Distribution is hard: 'gout flare' search volume is about 2 on the trends scale and GoutSnap leads with 260+ App Store reviews, so organic discovery will be slow.

Medium

Mitigation: Lead with r/gout and r/gout_and_diet engagement, a shareable trigger quiz and rheumatology clinic pilots rather than paid search; invest in app-store optimization for flare prediction.

06 · Economics

400 subscribers, $2.6K a month, a long road to millions

Estimates
What you sell
Free
Personal Flare Trigger Quiz & Starter Report
$0 (email required)
Entry
FlareCast Plus (trigger insights)
$3.99/mo
Core
FlareCast Predict (daily flare-risk signal)
$7.99/mo
Scale
FlareCast Care (clinician sharing and lab tracking)
$14.99/mo
Recurring
FlareCast Predict annual plan
$79/yr
Monthly revenue, year one $2.6K
Ceiling $3M-6M ARR $0.3K StartM3M6M9M12

Go-to-market

Channels
r/gout and r/gout_and_diet community engagement and beta recruitment Trigger-quiz lead magnet with email follow-up App Store optimization for 'gout flare predictor' and 'gout tracker' Rheumatology and primary care clinic pilots with doctor-ready reports Content built on the 2026 trial and regulatory news hooks
Launch strategy
Run a closed beta with 100-200 r/gout users, collect 8 weeks of data, and backtest prediction accuracy before the public launch. Launch with the headline 'predicts flares, shows why', using the Nov 2026 trial (85% vs 49% reaching the urate target with app-supported care) as the news hook. Be transparent about prediction limits and publish accuracy results to earn trust that competitors haven't.
First 100 users
Recruit beta testers in r/gout and r/gout_and_diet by answering threads such as 'Flare up for no apparent reason', 'URIC ACID tracker' and 'App recommendation to track food and check correlation to flare ups'. Follow with a clear beta invite and the free trigger quiz. Then DM users who ask for tracking apps, contact the developers and patients active in those threads, and pitch two or three rheumatology clinics a free doctor-report pilot. Search is not the wedge: 'gout flare' volume is only about 2.
Pricing validation
Before launch, show beta users three price points ($3.99 Plus, $7.99 Predict, $79/yr) against Gout-Cha! at €6.66/mo and €79.99/yr, and run a pre-sale for the first 100 users with a founding annual price. Track conversion at the paywall, and only keep paid prediction if accuracy feedback supports it.
07 · Build plan

Turn this research into a build plan

The wizard drafts the remaining steps from this idea in seconds.

Build this →
Problem
Done, from this research
2
Offer
3
Traffic
4
Funnel
5
Plan
Your project
Ready to kick off
08 · Agents

Run any agent on this idea

MCP connected
Pick one and it runs in Claude Code through your Builders MCP. All agents
09 · Napkin math

Year one, on a napkin

$15K-$30K year 1

What the first year looks like if the assumptions hold.

Store and web visitors, year one (assumption) 100,000
Visitor-to-install rate (assumption) 20%
Installs 20,000
Install-to-active-user rate (assumption) 40%
Active users 8,000
Free-to-paid rate (assumption) 5%
Paying subscribers, month 12 400
Share on annual plan (assumption) 40%
Blended net price per month (from the ladder) $6.50
MRR, end of year 1 $2.6K
ARR, end of year 1 $31K

Price anchors come from Gout-Cha! (€6.66/mo, €79.99/yr) and the market-size SOM ARPU of ~$55/yr; traffic, install, activation and conversion rates are guesses.

The ceiling if it compounds
$3M-6M ARR